SRSF2突变型慢性粒单核细胞白血病对cGAS-STING通路干预的脆弱性
本研究建立表达SRSF2P95H的斑马鱼CMML模型,重现骨髓增生异常、单核细胞增多及白血病转化。转录组分析显示剪接改变及cGAS-STING通路激活的炎症表型,伴DNA损伤、R环形成和双链DNA积聚。抑制R环或cGAS-STING轴可减轻炎症基因表达及白血病表型,并在人造血干祖细胞中验证。
要点
- SRSF2P95H斑马鱼模型重现CMML的骨髓增生异常、单核细胞增多和白血病转化。
- cGAS-STING通路激活与SRSF2P95H致病相关,抑制该通路可缓解白血病表型。
- R环形成和DNA损伤参与cGAS-STING激活,靶向R环或该通路具治疗潜力。
核心结论
- SRSF2P95H与cGAS-STING激活在CMML中存在致病关联,干预该通路可减轻白血病表型。
研究设计与样本
- 基于转基因SRSF2P95H表达的斑马鱼CMML模型,并进行人造血干祖细胞验证。
主要发现
- 转基因斑马鱼出现骨髓增生异常、单核细胞增多和白血病转化。
- 转录组分析证实全局剪接改变及cGAS-STING通路激活相关的炎症表型。
- DNA损伤、R环形成和双链DNA积聚明显。
- 抑制R环形成或cGAS-STING轴显著减少炎症和免疫激活相关基因表达,并减轻白血病表型。
- 炎症效应及其治疗反应在人造血干祖细胞中重现。
临床怎么用
- 靶向R环形成或cGAS-STING通路可能成为SRSF2突变型CMML的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic myelomonocytic leukemia (CMML) is characterized by monocytosis in blood and bone marrow and natural progression to acute myeloid leukemia (AML) in ≤30% of patients. The mutation landscape of CMML has been reported, and animal models that recapitulate its clinicopathologic features and progression are needed. We report a CMML zebrafish model based on transgenic SRSF2P95H expression that closely resembled the human disease. Hematological assessment of the transgenic animals showed myelodysplasia, monocytosis, and leukemia transformation. Transcriptomic analysis confirmed global splicing alterations and identified inflammatory phenotypes associated with activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway. DNA damage, R-loop formation, and double-strand DNA accumulation were evident. Inhibition of R-loop formation or cGAS-STING axis significantly reduced gene expression associated with inflammation and immune activation and mitigated the leukemia phenotype. The inflammatory effects and their response to treatment were recapitulated in human hematopoietic stem and progenitor cells. Collectively, our findings show a pathogenetic link between SRSF2P95H and cGAS-STING activation in CMML and its vulnerability to therapeutic intervention.
引用
- Chen Y, Chan KC, Sin CF, et al. Vulnerability of SRSF2-mutated chronic myelomonocytic leukemia to perturbation of the cGAS-STING pathway. Blood Adv. 2026. PMID: 41346291. doi:10.1182/bloodadvances.2025017005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。